Does CABOTEGRAVIR Cause Off label use? 1,049 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,049 reports of Off label use have been filed in association with CABOTEGRAVIR (Apretude). This represents 12.6% of all adverse event reports for CABOTEGRAVIR.
1,049
Reports of Off label use with CABOTEGRAVIR
12.6%
of all CABOTEGRAVIR reports
15
Deaths
12
Hospitalizations
How Dangerous Is Off label use From CABOTEGRAVIR?
Of the 1,049 reports, 15 (1.4%) resulted in death, 12 (1.1%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 1,049 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
Product complaint (213)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CABOTEGRAVIR Alternatives Have Lower Off label use Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL